Ersoy B, Gökşen D, Darcan S, Mavi E, Oztürk C
Department of Pediatric Endocrinology, Ege University Faculty of Medicine, Izmir-Turkey.
Indian J Pediatr. 1999 May-Jun;66(3):375-9. doi: 10.1007/BF02845528.
Multiple studies have documented reduction in peripheral bone mass in children with insulin dependent diabetes mellitus (IDDM). In this study, the bone mineral density (BMD) of the lumbar vertebrae (L2-L4) was measured by dual photon absorptiometry in 14 female and 16 male diabetic patients of age 11 to 16 years with varying clinical duration. Twenty three children between 11 to 16 years with normal anthropometric measurements between 10th and 97th percentile and no known history of metabolic bone disease served as a control group. BMD values, weight, height, body mass index, metabolic, biochemical and growth parameters of the study group were compared with those of the control group. BMD (L2 AP 0.732 +/- 0.15 gm/cm2, L2 lateral 0.534 +/- 0.09 gm/cm2 in the study group and 0.812 +/- 0.63 gm/cm2 and 0.619 +/- 0.20 gm/cm2 in the control group) and osteocalcin (10.10 +/- 3.40 ng/ml and 23.12 +/- 2.74 ng/ml in diabetes and control respectively) levels were significantly lower in diabetic patients (p < 0.05, p < 0.01 respectively). Within the study group BMD correlated positively with age but not with the duration of the disease nor with the level of metabolic control.
多项研究已证明,胰岛素依赖型糖尿病(IDDM)患儿的外周骨量会减少。在本研究中,采用双能光子吸收法测量了14名女性和16名男性11至16岁、临床病程各异的糖尿病患者腰椎(L2-L4)的骨矿物质密度(BMD)。选取23名年龄在11至16岁、人体测量指标处于第10至97百分位之间且无代谢性骨病已知病史的儿童作为对照组。将研究组的BMD值、体重、身高、体重指数、代谢、生化及生长参数与对照组进行比较。糖尿病患者的BMD(研究组L2前后位为0.732±0.15 g/cm²,L2侧位为0.534±0.09 g/cm²;对照组为0.812±0.63 g/cm²和0.619±0.20 g/cm²)和骨钙素水平(糖尿病组和对照组分别为10.10±3.40 ng/ml和23.12±2.74 ng/ml)显著更低(分别为p<0.05,p<0.01)。在研究组中,BMD与年龄呈正相关,但与病程及代谢控制水平无关。